Company Filing History:
Years Active: 2013
Title: Ginger Chao: Innovator in Bispecific Binding Molecules
Introduction
Ginger Chao is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of bispecific binding molecules. Her innovative work has the potential to impact diagnostic, research, and therapeutic applications.
Latest Patents
Ginger Chao holds a patent for bispecific EGFR/IGFIR binding molecules. This invention relates to bispecific molecules that comprise an EGFR binding domain and a distinct IGFIR binding domain. These molecules are designed for use in various applications, including diagnostics and therapeutics. The invention also encompasses cells that contain such proteins, polynucleotides encoding these proteins or their fragments, and vectors that include the polynucleotides. Notably, exemplary bispecific molecules include antibody-like protein dimers based on the tenth fibronectin type III domain. She has 1 patent to her name.
Career Highlights
Ginger Chao is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology.
Collaborations
Ginger collaborates with esteemed colleagues, including Stuart Emanuel and Linda Engle. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Ginger Chao is a trailblazer in the field of bispecific binding molecules, with a focus on innovative solutions for medical applications. Her contributions are paving the way for advancements in biotechnology and therapeutic development.